IPP Bureau
Medicamen Biotech posts Rs. 3.64 Cr consolidated PAT in Q4FY21
By IPP Bureau - June 27, 2021
The company has posted net profit of Rs.12.12 crores for the 12 months period ended March 31, 2021
Lupin Launches Emtricitabine and Tenofovir Disoproxil Fumarate Tablets in the US
By IPP Bureau - June 27, 2021
It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection.
Zydus Cadila receives tentative approval from USFDA for Pemetrexed
By IPP Bureau - June 26, 2021
Pemetrexed is used to treat certain types of cancers such as lung cancer, mesothelioma. It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells
Glenmark receives ANDA tentative approval for Nintedanib Capsules
By IPP Bureau - June 26, 2021
According to IQVIA sales data for the 12 month period ending April 2021, the Ofev Capsules, 100 mg and 150 mg market achieved annual sales of approximately US $1.6 billion
Shilpa Medicare receives DRDO approval for 2DG manufacturing
By IPP Bureau - June 26, 2021
2DG has been given emergency approval by the Drug Controller General of India for COVID-19 patients in the country
Zydus Cadila receives USFDA approval for Fingolimod capsules
By IPP Bureau - June 25, 2021
Fingolimod is an immunomodulating drug. It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis
Poxel and Sumitomo Dainippon gets TWYMEEG approval
By IPP Bureau - June 25, 2021
The TWYMEEG approval is supported by numerous preclinical and clinical studies, including the Phase 3 TIMES (Trials of IMeglimin for Efficacy and Safety) program managed jointly by both the companies
Glenmark receives ANDA approval for inhalation solution
By IPP Bureau - June 24, 2021
Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials will be manufactured in the company’s North American manufacturing facility based in Monroe, North Carolina
Cipla receives final approval for generic version of Brovana
By IPP Bureau - June 24, 2021
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
Sun Pharma settles patent litigation for Revlimid
By IPP Bureau - June 23, 2021
Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture and sell certain generic lenalidomide capsules
Vaishali Pharma bags $100,000 order from Russia
By IPP Bureau - June 23, 2021
The company has predominantly built a portfolio into veterinary products
Shilpa Medicare launches dissolving oral thin films of Paracetamol
By IPP Bureau - June 23, 2021
Shilpa's Paracetamol oral thin films are patent protected and are first of this kind in the world
Honeywell launches solutions to prevent counterfeit pharma products
By IPP Bureau - June 23, 2021
The end user can validate the authenticity of the product by scanning the digital code with the help of a smartphone letting the end user know it is safe to use
Zydus and Bayer announce extension of their JV
By IPP Bureau - June 21, 2021
Bayer Zydus Pharma will continue to operate in core therapies with new products in the pipeline
Mangalam Drugs commissions intermediate manufacturing facility
By IPP Bureau - June 19, 2021
This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent
